Farallon Capital Management LLC Liquidia Corp Put Options Transaction History
Farallon Capital Management LLC
- $22.3 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding LQDA
# of Institutions
209Shares Held
47.5MCall Options Held
1.61MPut Options Held
1.15M-
Black Rock Inc. New York, NY4.24MShares$95 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$80.5 Million0.0% of portfolio
-
Findell Capital Management LLC New York, NY3MShares$67.2 Million18.2% of portfolio
-
Opaleye Management Inc. Boston, MA2.48MShares$55.5 Million7.37% of portfolio
-
Goldman Sachs Group Inc New York, NY2.42MShares$54.2 Million0.0% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $1.44B
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...